๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment

โœ Scribed by Noriyo Yamashiki; Haruhiko Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Hideo Yoshida; Yuji Kondo; Takamasa Oki; Takao Kawabe; Masao Omata


Book ID
108951190
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
118 KB
Volume
22
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Hepatocellular carcinoma: Agents and con
โœ Hans J. Schlitt; Andreas A. Schnitzbauer ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB

1. Adjuvant/neoadjuvant chemotherapy. 2. Neoadjuvant transarterial chemoembolization. 3. Kinase inhibitors (eg, sorafenib). 4. Antiviral treatment. 5.Immunosuppressive treatment after liver transplantation. 6. Disseminated tumor cells: the basis for innovative treatment options?

Patterns of intrahepatic recurrence afte
โœ Takashi Matsumata; Takashi Kanematsu; Kenji Takenaka; Yasuhiro Yoshida; Takashi ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 371 KB

Using selective angiograms of the liver, we analyzed the patterns of intrahepatic recurrence of hepatocellular carcinomas following curative surgery. In 33 patients with intraheptaic recurrences, seven patients (2 1 %) had a recurrence near the resected hepatic stump. The remaining 26 had either a n